What this topic covers
Natural killer cell engineering, innate immunotherapy, persistence, targets, and clinical studies. PaprFeed links each result back to the original source record.
Topic feed
Browse recent NK cell therapy papers from PubMed, arXiv, bioRxiv, and medRxiv. Natural killer cell engineering, innate immunotherapy, persistence, targets, and clinical studies.
Natural killer cell engineering, innate immunotherapy, persistence, targets, and clinical studies. PaprFeed links each result back to the original source record.
Start with NK cell therapy, then refine inside PaprFeed by source, date range, paper type, or a narrower phrase.